Tyco’s Respiratory Unit Receives Fourth FDA Warning Letter This Year
This article was originally published in The Gray Sheet
Executive Summary
Tyco Healthcare has received four warning letters from FDA citing quality systems deficiencies in its respiratory products division in the last eight months